Comparing cyclosporine and methotrexate for kids with alopecia areata
Treatments studied
Part of Skin clinical trials.
This study compares two medicines, cyclosporine and methotrexate, to see which works better for children with alopecia areata (a condition causing hair loss). It aims to help doctors choose the best treatment for each child.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 2 to 17 years old
- Diagnosed with alopecia areata by a skin doctor (dermatologist)
- Willing to take study medicine and come to clinic visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medications, tofacitinib and methotrexate, to see which works better for severe hair loss caused by alopecia areata. If you have severe alopecia areata (total or universal hair loss), this study may offer a chance to try a new treatment option.
This trial tests a new drug, HCW9302, that targets the immune system to help hair regrow in people with alopecia areata (including extensive forms like totalis or universalis). It may be an option for adults who have not responded well to other treatments.
This trial compares two common medicines, hydroxychloroquine and methotrexate, to see which works better for treating frontal fibrosing alopecia (a type of hair loss). You and your doctor can choose which treatment you prefer.
This trial compares two medications, hydroxychloroquine and methotrexate, to see which works better for treating lichen planopilaris (a scalp condition that causes hair loss). Patients can choose their treatment or be assigned based on their health needs.
This study tests if a cream containing methotrexate (a medicine that affects the immune system) can help regrow hair in people with mild alopecia areata (patchy hair loss on the scalp). It compares the methotrexate cream to a standard treatment cream (minoxidil) to see which works better.
This trial tests if methotrexate, a medication that calms the immune system, can help adults with moderate-to-severe eczema that hasn't improved with creams or other treatments. You'll either receive methotrexate or a placebo to see which works better.
Hear when a new Alopecia Areata(AA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.